Abstract: Singlet oxygen is believed to be the species destroying cancerous cells during PDT. An optically-based imaging device for monitoring singlet oxygen production in a tumor was developed and tested in-vivo.
Introduction
Photodynamic therapy (PDT) has been found to be a promising treatment for cancer [1, 2] . PDT uses the affinity of photosensitizers (PS) to be selectively retained in malignant tumors. When tumors, pretreated with the PS, are irradiated with visible light, a photochemical reaction occurs and tumor cells are destroyed. There is compelling evidence that O 2 ( 1 ∆), also known as singlet oxygen, is the active species in cancer cell destruction in tumors containing PS [2] . The ability to correlate the amount of singlet oxygen produced to the percentage of cancer cell destruction could lead to more efficacious treatments as well as a better understanding of the tumor destruction mechanism. In addition, the effects of dye bleaching and oxygen consumption could be monitored. It is very critical to know the exact tumor sites and to target tumor effectively without damaging healthy cells. Therefore, imaging both tumor cells with PS fluorescence and singlet oxygen emission can provide very powerful guidance for developing PDT treatment. It will allow one to target tumor cells more precisely and monitor singlet oxygen in realtime simultaneously with the irradiation treatment.
Previously, we developed a prototype, non-imaging point sensor for PDT produced singlet oxygen [3] . This ultra-sensitive device was used to detect singlet oxygen phosphorescence at ~ 1.27 µm in-vivo both in animal and human studies. This provided the ground work for developing an imaging sensor, and the work reported in this paper is a significant extension of that work. In both the point sensor and the imaging sensor reported here, we used a pulsed diode laser that operates in a pulsed mode with an average power of ~ 3 mW. The energy/pulse is typically <1 µJ, and the pulse repetition rate can be as high as 20 kHz.
We have developed and demonstrated a 2D imaging system and successfully produced spatially resolved images of PS and singlet oxygen both in-vitro and in-vivo. The in-vivo images were from mice containing tumor models.
A fully developed instrument will be a valuable tool for several aspects of PDT research including: elucidating kinetic and physiological phenomena, assessing new PS targeted to specific tissue areas, correlating PS concentrations with singlet oxygen production, and evaluating the relationship between singlet oxygen production with tumor regression.
Experiments
Near-IR and visible cameras were used for simultaneous images of the respective singlet oxygen and PS spatial profiles. The near-IR camera uses a high quantum efficiency photocathode and an electron bombardment intensifier to provide near single-photon detection in the 1 to 1.5 µm spectral region. We used a fiber coupled diode lasers each having an appropriate wavelength for each PS: 635 nm for protoporphyrin IX (Pp IX) and 660 nm for chlorin e6 (Cl-e6) to excite the PS solutions.
To differentiate the singlet oxygen emission at 1.27 µm from the bright PS fluorescence and any background signal (spectral discrimination), we used a set of filters (1.21, 1.27, and 1.33 µm) to detect emissions of singlet oxygen and background signals. The images at 1.21 and 1.33 µm contain only PS fluorescence and the image at 1.27 µm contains contributions from both the singlet oxygen and PS. Therefore, the singlet oxygen signal is calculated from 1.27 µm signal with subtraction of average signal of 1.21 and 1.33 µm. Fig. 1 shows the schematic of the imaging sensor: excitation diode laser, near-IR camera, and visible camera. 
Results
In-vitro studies of the imaging system, we used two photosensitizers, Cl-e6 and Pp IX in several solvents including protein-laden aqueous solutions that are severe quenchers of singlet oxygen. Fig. 2 shows the images of both the singlet oxygen emission and Cl-e6 fluorescence with in-vitro samples as a function of the PS (Cl-e6) concentration. The intensities of singlet oxygen and PS fluorescence were integrated and plotted in Fig. 2(b) . There is a good correlation between singlet oxygen produced by light treatment and PS fluorescence. We also demonstrated high spatial resolution, sensitive imaging of a tumor model on mice using the high resolution, near-IR camera. Fig. 3 shows images of singlet oxygen and PS fluorescence during a PDT treatment for a control mouse and a tumor-loaded mouse. The control mouse had no tumor, so the injected PS dye was spread through the entire body. The weak singlet oxygen emission and PS fluorescence were observed due to PS dye spread and defined by where PDT excitation light was illuminated. Comparing to the control case, tumor-loaded mice showed much higher intensities of singlet oxygen and PS fluorescence from the tumor area due to the accumulation of PS in the tumor. We believe these are the first reported spatial images of singlet oxygen emission from live animals. 
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